BioCentury
ARTICLE | Clinical News

Actiq oral transmucosal form of fentanyl: NSTA completed patient enrollment in Phase III trials

July 29, 1996 7:00 AM UTC

Anesta Corp. (NSTA), Salt Lake City, Utah Product: Actiq oral transmucosal form of fentanyl, a narcotic Indication: Breakthrough pain in cancer Status: NSTA completed patient enrollment in Phase III ...